γδT Cell Infusion to Prevent Relapsed/Refractory Leukemia Rescue Relapse

Clinical trial NCT04439721 · UNKNOWN

Trial details

NCT number: NCT04439721
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Leukemia, B-cell

Start date: 2020-05-01
Primary completion: 2021-05-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.